ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,658Medicare Part D Prescriptions Filled, Including Refills

Rank: 50 out of 252

$554K Total Retail Price of All Prescriptions

Rank: 86 out of 252

477 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
57% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 477 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 10,685 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
FUROSEMIDE 608 466 1 7
SIMVASTATIN 540 459 2 2
LISINOPRIL 498 401 3 3
AMLODIPINE BESYLATE 446 385 4 4
METFORMIN HCL 439 353 5 9
HYDROCODONE-ACETAMINOPHEN 362 219 S3 6 5
LEVOTHYROXINE SODIUM 351 275 7 1
OMEPRAZOLE 343 291 8 6
METOPROLOL TARTRATE 335 229 9 10
POTASSIUM CHLORIDE 295 247 10 8
HYDROCHLOROTHIAZIDE 252 190 11 13
DIGOXIN 216 186 12 44
METOPROLOL SUCCINATE 207 193 13 19
TRAMADOL HCL 185 136 14 17
WARFARIN SODIUM 160 150 15 14
ZOLPIDEM TARTRATE 155 100 16 21
GLIMEPIRIDE 139 118 17 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 133 120 18 25
FAMOTIDINE 132 112 19 59
DONEPEZIL HCL 131 131 20 28
CIPROFLOXACIN HCL 125 88 21 61
GABAPENTIN 125 78 21 11
PRAVASTATIN SODIUM 123 91 23 12
SUCRALFATE 119 88 24 125
CITALOPRAM HBR 114 84 25 15
CLOPIDOGREL 113 102 26 29
NAMENDA 112 112 27 41
LANTUS 109 82 28 55
CLONIDINE HCL 109 70 28 35
PANTOPRAZOLE SODIUM 104 98 30 62
MELOXICAM 100 90 31 20
CYCLOBENZAPRINE HCL 99 61 R 32 51
KLOR-CON 10 98 97 33 146
TRIAMTERENE-HCTZ 97 87 34 33
POLYETHYLENE GLYCOL 3350 96 85 35 67
NEXIUM 96 54 35 23
PLAVIX 96 88 35 43
TAMSULOSIN HCL 91 58 38 26
KLOR-CON M20 91 84 38 69
AZITHROMYCIN 90 68 40 37
ISOSORBIDE MONONITRATE ER 85 74 41 50
DIOVAN HCT 84 63 42 65
ATORVASTATIN CALCIUM 84 84 42 16
ATENOLOL 80 70 44 18
LOSARTAN-HYDROCHLOROTHIAZIDE 78 78 45 49
DOXYCYCLINE HYCLATE 76 64 46 92
ALENDRONATE SODIUM 71 71 47 32
ADVAIR DISKUS 71 51 47 63
ETODOLAC 71 37 47 199
AMLODIPINE BESYLATE-BENAZEPRIL 68 68 50 60
QUETIAPINE FUMARATE 64 52 51 77
VERAPAMIL ER 63 63 52 83
SPIRONOLACTONE 63 42 52 53
GLYBURIDE-METFORMIN HCL 62 41 R 54 82
ACETAMINOPHEN-CODEINE 60 39 S3 55 117
MIRTAZAPINE 60 44 55 58
NABUMETONE 60 17 55 196
METHYLPREDNISOLONE 60 36 55 118
SERTRALINE HCL 59 39 59 27
LOVASTATIN 58 54 60 39
LOSARTAN POTASSIUM 58 45 60 24
ESTRADIOL 57 57 R 62 76
PHENYTOIN SODIUM EXTENDED 55 26 63 103
GLYBURIDE 53 52 R 64 78
ENALAPRIL MALEATE 51 42 65 72
AMIODARONE HCL 50 27 66 142
IBUPROFEN 50 38 66 130
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 20, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.